Latest filing published 07 Mar 2025 for FIBROGEN INC, €2,532.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Christine Chung: trading record in brief
This profile gathers the share dealings of Christine Chung in Kyntra Bio, Inc., where the filings describe the role as senior executive. The record holds 114 filings, for trades running from 7 May 2019 to 6 March 2025.
Sales make up the whole of the open-market record (52 sales, €5.3M). Other entries cover 38 share grants and 24 option exercises.
The latest filing, published on 7 March 2025, reports a share grant in Kyntra Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Christine Chung
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,008 shares@ US$0.390.2% of flowCommon StockSEC:0001415889-25-007457:0
- 2,792 shares@ US$0.34210.1% of flowCommon StockSEC:0001415889-24-028742:0
- 17,395 shares@ US$0.390.6% of flowCommon StockSEC:0001415889-24-023088:0
- 19,289 shares@ US$1.192.0% of flowCommon StockSEC:0001415889-24-016080:0
- 23,168 shares@ US$1.873.7% of flowCommon StockSEC:0001415889-24-007451:0
- 29,000 shares0Common StockSEC:0001415889-24-005154:0
- 18,182 shares@ US$0.580.9% of flowCommon StockSEC:0001209191-23-058052:0
- 3,308 shares@ US$0.96310.3% of flowCommon StockSEC:0001209191-23-048808:0
- 120,000 shares0Common StockSEC:0001209191-23-048029:0
- 6,250 shares@ US$17.609.5% of flowCommon StockSEC:0001209191-23-037604:0
- 1,362 shares@ US$17.03532.0% of flowCommon StockSEC:0001209191-23-036064:0
- 6,590 shares@ US$18.783810.6% of flowCommon StockSEC:0001209191-23-023591:0
- 8,354 shares@ US$21.155915.6% of flowCommon StockSEC:0001209191-23-018065:0
- 25,000 shares0Common StockSEC:0001209191-23-012426:0
- 1,851 shares@ US$12.262.1% of flowCommon StockSEC:0001209191-23-001351:0
- 2,595 shares@ US$15.793.6% of flowCommon StockSEC:0001209191-23-001354:0
- 1,096 shares@ US$15.791.5% of flowCommon StockSEC:0001209191-22-060582:0
- 4,683 shares@ US$13.015.8% of flowCommon StockSEC:0001209191-22-052392:0
- 518 shares@ US$12.260.6% of flowCommon StockSEC:0001209191-22-049225:0
- 1,850 shares@ US$9.503.8% of flowCommon StockSEC:0001209191-22-035220:0
- 4,682 shares@ US$12.025.6% of flowCommon StockSEC:0001209191-22-022097:0
- 3,905 shares@ US$12.695.0% of flowCommon StockSEC:0001209191-22-017649:0
- 45,000 shares0Common StockSEC:0001209191-22-010449:0
- 5,284 shares@ US$14.827.6% of flowCommon StockSEC:0001209191-22-001740:0
- 2,668 shares@ US$14.193.7% of flowCommon StockSEC:0001209191-21-068506:0
25 of 28 declarations
